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Background: Europe faces an enormous public health challenge with aging populations and rising cancer
incidence. Little is known about what concerns the public across European countries regarding cancer care towards
the end of life. We aimed to compare the level of public concern with different symptoms and problems in
advanced cancer across Europe and examine factors influencing this.
Methods: Telephone survey with 9,344 individuals aged ≥16 in England, Flanders, Germany, Italy, Netherlands,
Portugal and Spain. Participants were asked about nine symptoms and problems, imagining a situation of advanced
cancer with less than one year to live. These were ranked and the three top concerns examined in detail. As
‘burden to others’ showed most variation within and between countries, we determined the relative influence of
factors on this concern using GEE and logistic regression.
Results: Overall response rate was 21%. Pain was the top concern in all countries, from 34% participants (Italy) to
49% (Flanders). Burden was second in England, Germany, Italy, Portugal, and Spain. Breathlessness was second in
Flanders and the Netherlands. Concern with burden was independently associated with age (70+ years, OR 1.50;
95%CI 1.24-1.82), living alone (OR 0.82, 95%CI 0.73-0.93) and preferring quality rather than quantity of life (OR 1.43,
95%CI 1.14-1.80).
Conclusions: When imagining a last year of life with cancer, the public is not only concerned about medical
problems but also about being a burden. Public education about palliative care and symptom control is needed.
Cancer care should include a routine assessment and management of social concerns, particularly for older patients
with poor prognosis.Background
Europe is facing an enormous public health and clinical
challenge with aging populations [1] and rising cancer
incidence [2]. Cancer treatment has advanced over the
last decades, which means that patients live longer ex-
periencing more co-morbidities [3]. Epidemiological
changes and technological advances increasingly influ-
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distribution, and reproduction in any mediumand dying. For example, news reports about cancer fre-
quently discuss aggressive treatment and survival but
rarely treatment failure, adverse events, end-of-life care,
or death [4].
Public views are reflected in each person diagnosed with
cancer. Although clinicians responsible for breaking bad
news to patients and families are aware of risks, symptoms
and problems associated with various cancers and their
treatments, there is little evidence to guide them on what
the level of public understanding is [5]. This is important
to ensure appropriate communication from the point of
diagnosis. In about 50% of cases, the person will not sur-
vive from cancer [6]. Communication is then even moretral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Survey question about most concerning symptoms
and problems
Which of the following nine symptoms or problems do you think would
concern you the most?
A. So which of the following nine symptoms or problems do you think
would concern you most?
B. And in second place?
List of problems 1st place 2nd place
(1st most
concerning)*
(2nd most
concerning)*
1. Having no energy
2. Being in pain
3. Changes in the way you look
4. Having no appetite at all
5. Being a burden to others
6. Being unable to get your breath
7. Being alone
8. Feeling as if you want to be sick
9. Being worried and distressed
* scoring: 2 = first most concerning; 1 = second most concerning; 0 = if not
selected as first or second most concerning.
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burden in advanced cancer is high, with pain, breathless-
ness, and fatigue occurring in over 50% of patients [7].
They will also know that impeccable assessment and ad-
vanced symptom management grounded on palliative care
will control most symptom discomfort [8]. However, there
is a dearth of research to show clinicians the main con-
cerns of people thinking of a situation of advanced cancer.
The few existing studies suggest that the public perceived
cancer as an extremely painful disease [9], that pain and
symptom control comprise main needs in terminal illness
[10], and that saying goodbye to loved ones and dying with
dignity are essential for a good death [11]. No study has
compared public opinion between countries to understand
cultural differences. Cross-national research into this topic
is important to inform European end of life care policy,
education, and research [12].
This study aimed to compare the level of public con-
cern with different symptoms and problems in advanced
cancer across varied European countries, and examine
factors influencing this.
Methods
Design
Population-based telephone survey in seven European
countries. Details are described elsewhere [13].
Participants and settings
The survey was conducted in Flanders (Dutch-speaking
part of Belgium), England, Germany, Italy, the
Netherlands, Portugal and Spain. The countries were
chosen as they participated in a European collaborative
(PRISMA) with the aim to promote best practice in the
measurement of end-of-life care, setting an agenda and
guidance that reflects European cultural diversity, and is
informed by both public and clinical priorities [14].
Residents ≥16 years were invited to take part in a
computer-assisted telephone interview (CATI). Private
households were selected using random digit dialling
(RDD), a method to generate a random sample of tele-
phone numbers. The sampling frame was obtained via
well-established sampling organisations with a proven
record of successfully supplying random samples of
telephone numbers to the research industry for over
15 years. The organisations were selected via a strict
tendering process and followed a technical specifica-
tion of work in order to adhere to exacting all meth-
odological, quality and ethical aspects specified by the
research team. No quotas (geographic or socio-
demographic) were used for sample generation.
Exclusion criteria were incapacity to understand the
information and provide informed consent (assessed by
interviewers), and inadequate language skills of the
country’s dominant language.Questionnaire
The questionnaire was developed using a multi-method
approach to enhance validity and comparability. This
included a review of studies on preferences and prior-
ities for care in advanced cancer, a review of cross-
national surveys, and three consultation rounds with
27 palliative care experts. The questionnaire contained
28 questions on preferences and personal values re-
lated to care in a scenario imagining ‘a situation of
serious illness, for example cancer, with less than one
year to live’. Participants were also asked about their
experience with illness, death and dying, their general
health and socio-demographics.
One survey component assessed participants’ level of
concern regarding nine symptoms and problems which
have been chosen based on the above mentioned multi-
method approach (see Table 1).Translation and testing
A formal linguistic process included translation in a
systematic and culturally sensitive way into the coun-
tries’ dominant language. Following the EORTC trans-
lation procedure, forward and backward translations
were prepared by two independent native-speakers
knowing about end-of-life care and a professional
translator [15]. All language versions were harmo-
nized through discussion of country representatives
and the final questionnaire was tested and piloted in
England and Germany with 30 volunteers using cogni-
tive interviewing [12].
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The interviews were conducted by 149 trained inter-
viewers experienced in telephone surveys on social and
health issues from May to December 2010. As part of
the questionnaire, participants were asked which of nine
named symptoms or problems would concern them the
most and which would concern them in second place
(first/second concern) (Table 1). Interviewers ensured
that at least four call-backs were made at different times
of the day (with at least one after 6 p.m.) to attempt to
reach all potential participants. 10% of interviews were
checked by in-situ supervisors for accuracy and inter-
viewer performance, and the research team randomly
audited the interviews in real-time.
Statistical analyses
Sample characteristics were described using crude per-
centages. First, we derived individual concern scores for
each of the nine symptoms and problems and ranked
them within and between countries. We then described
the three greatest concerns across all countries in more
detail.
Second, we determined which of the top three con-
cerns showed most variation to identify influencing fac-
tors. Although pain was of most concern, burden
showed more variation within and between countries
and less consistency than pain. Thus, we then carried
out a more detailed analysis of factors associated with
choosing burden as a top concern. We compared crude
percentages of participants for whom burden was a top
concern (first/second concern) with those who ranked it
“not most concerning” (i.e. neither first nor second
most concerning) and tested for differences in bivariate
analyses using t-test for age and χ2-tests and Mann–
Whitney U tests for other variables.
To examine factors associated with choosing burden
as a top concern across countries we used generalised
estimating equations (GEE). This modelling technique
takes into account clustering effect within countries, as-
suming that participants from one country are more
likely to have similar views compared to participants
from other countries [16]. We entered significant vari-
ables from bivariate analysis associated with the concern
about being a burden (first/second most concerning ver-
sus neither first nor second most concerning, p ≤ 0.05)
in the GEE model, using data from all countries where
the direction of effect was consistent across countries
and also significant data from individual countries. We
estimated the odds ratio (OR) associated with different
levels of each independent variable retained in the final
model (ORs are presented with 95% CIs).
Finally, we conducted logistic regressions within each
country, entering factors from the cross-national GEE
model (to confirm applicability to individual countries)and other country-specific factors associated with this
concern in the bivariate analysis (p ≤ 0.05).
We undertook all analyses using SPSS for Windows
(version 19.0.0, 2010; SPSS, Inc, an IBM Company,
Chicago, IL). Tests were two-tailed and p ≤ 0.01 was
deemed significant in the final models to allow for
multiple testing.
Ethics approval
The study was approved by the research ethics commit-
tee of King’s College London, the lead academic centre
(BDM/08/09-48). Local research ethics approvals and/or
notifications to relevant national data protection agen-
cies were obtained in all countries.
Results
9,344 people (21%) agreed to participate from 45,242
randomly selected households. The response rate varied
across countries, being highest in Germany (29%) and
Portugal (28%), followed by Spain, Italy and England
(21% each), with Flanders and the Netherlands (each
16%) lowest. Interview completion time averaged
15.4 min (range 3 to 91 min). Main specified reasons for
refusal were lack of interest (59%), lack of time (17%)
and refusal to take part in telephone surveys (3%). A de-
tailed description for reasons to refuse to take part is
available elsewhere [13].
Mean age was 50.7 years, 66% were female and 17%
were living alone varying from 24% in England to 11% in
Italy and Portugal. 64% described themselves as being
religious or belonging to a denomination, ranging from
46% in the Netherlands to 82% in Italy. Ten percent of
the participants had been seriously ill in the past five
years, and 53% had cared for a close relative or friend in
their last months of life (Table 2).
Top concerning symptoms
In all seven countries, pain was the top concern for
34% of participants in Italy to 49% in Flanders (Figures 1
and 2). ‘Being a burden’ was the second concern in
Spain (34%), Italy (28%), England (26%), Germany, and
Portugal, but not in the Netherlands and Flanders
where breathlessness was ranked second. In the other
five countries, breathlessness and ‘being alone’ ranked
third or fourth place.
Factors influencing concern with ‘being a burden’
Detailed bivariate analyses on concern with ‘being a
burden’ are presented in Table 3. Across all countries,
concern with burden showed a u-shape relationship
with age; it was more frequent among younger (16–
29 years; 43.9%) and older people (70+ years; 48.1%)
with the lowest point among 40–49 year olds (40.2%;
z = 2.347, p = 0.019). In the whole sample, those living
Table 2 Participant characteristics by country
England Flanders Germany Italy Netherlands Portugal Spain All
countries
N = 1351 N = 1269 N = 1363 N = 1352 N = 1356 N = 1286 N = 1367 N = 9344
Age
Mean in years (SD) 54.18
(16.27)
52.18
(14.27)
47.06
(15.71)
48.67
(15.92)
54.53
(14.62)
50.10
(16.85)
48.08
(16.45)
50·68
(16·00)
16-29 8.0% 7.5% 15.8% 15.0% 4.7% 13.8% 15.4% 11.5%
30-39 11.3% 10.2% 14.6% 14.1% 9.7% 14.4% 16.1% 12.9%
40-49 19.1% 22.3% 26.8% 20.4% 22.3% 18.9% 21.0% 21.6%
50-59 19.4% 27.0% 20.3% 23.1% 24.2% 20.1% 22.2% 22.2%
60-69 23.8% 21.9% 13.7% 17.7% 23.6% 18.5% 14.9% 19.1%
70+ 18.3% 11.0% 8.8% 9.7% 15.4% 14.3% 10.5% 12.6%
Gender
Female 63.9% 65.6% 58.0% 72.0% 65.8% 69.4% 68.4% 66.1%
Living arrangements
Living alone 24.2% 15.6% 20.8% 10.5% 21.8% 10.6% 11.5% 16.5%
Urbanisation level
Big city or suburbs/outskirts 37.1% 22.8% 40.9% 19.9% 26.8% 50.0% 23.7% 31.5%
Town or small city 36.7% 17.7% 30.8% 39.0% 23.0% 28.6% 43.1% 31.4%
Country village 21.3% 46.6% 22.1% 38.6% 42.7% 17.2% 29.4% 31.1%
Farm or home in countryside 4.9% 13.0% 6.2% 2.5% 7.6% 4.2% 3.8% 6.0%
Marital status
Married or with a partner 61.3% 75.7% 58.1% 63.8% 69.2% 63.6% 62.2% 64.8%
Divorced or separated 13.1% 8.0% 11.3% 6.4% 8.2% 7.1% 7.3% 8.8%
Widowed 9.8% 7.6% 6.2% 6.8% 10.5% 8.5% 8.3% 8.3%
Single 15.8% 8.8% 24.5% 23.0% 12.0% 20.7% 22.1% 18.2%
Religion
With a religion or denomination 57.9% 52.9% 57.0% 81.6% 45.6% 79.6% 71.0% 63.6%
Health
Very good 42.0% 38.6% 22.9% 22.6% 22.3% 13.3% 21.5% 26.1%
Good 39.8% 46.0% 51.5% 47.6% 55.3% 38.1% 41.1% 45.7%
Fair 14.2% 13.9% 21.3% 28.0% 18.8% 43.6% 32.0% 24.5%
Bad 3.5% 1.3% 3.9% 1.6% 3.2% 3.6% 4.9% 3.1%
Very bad 0.5% 0.2% 0.4% 0.2% 0.4% 1.5% 0.5% 0.5%
Experience of illness, death and dying
Diagnosed with seriously illness in last 5 years 12.8% 15.2% 8.0% 8.4% 10.1% 7.8% 8.8% 10.1%
Close relative/friend seriously ill in last 5 years 63.1% 60.6% 64.1% 67.4% 71.8% 57.5% 68.2% 64.8%
Death of close relative/friend in last 5 years 70.6% 69.9% 69.4% 69.3% 76.7% 60.9% 74.4% 70.3%
Cared for close relative/friend in last months of life 50.6% 49.9% 48.0% 60.8% 52.0% 53.2% 57.0% 53.1%
Legend: Sums may not always amount to the total sample number because of missing values on variables. Percentages may not always add up to 100 because of
rounding. SD = standard deviation.
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those living with others (43.9% vs. 39.7% respectively,
χ2 = 8.43, p = 0.004) but at a country level this effect
was significant only in England (53.4% vs.45.6%; χ2 = 5.75,
p = 0.016); in Portugal it was observed the opposite
(31.9% vs. 42.9%; χ2 = 5.20, p = 0.023). Perceptions ofone’s own health and personal experiences of illness,
death and dying did not affect concern with burden. In
the whole sample, burden concern was highest amongst
participants who preferred care on improving the qual-
ity rather than the quantity of life across all countries
(χ2 = 18.80, p = <0.0001); this also reached significance
Symptoms and problems England Flanders Germany Italy Netherlands Portugal Spain
sum (rank) sum (rank) sum (rank) sum (rank) sum (rank) sum (rank) sum (rank)
Being in pain 2849 (1) 2728 (1) 2753 (1) 2429 (1) 2617 (1) 2362 (1) 2565 (1)
Being a burden to others 2312 (2) 1697 (3) 2170 (2) 2298 (2) 1751 (3) 1958 (2) 2552 (2)
Being unable to get your breath 1676 (4) 1759 (2) 2103 (3) 1656 (4) 2088 (2) 1701 (3) 1718 (4)
Being alone 1681 (3) 1696 (4) 1773 (4) 1811 (3) 1616 (4) 1616 (4) 1779 (3)
Having no energy 1473 (5) 1638 (5) 1564 (5) 1514 (5) 1602 (5) 1506 (5) 1565 (5)
Being worried and distressed 1473 (5) 1333 (7) 1435 (6) 1488 (6) 1465 (8) 1489 (6) 1424 (6)
Changes in the way you look 1405 (8) 1334 (6) 1429 (7) 1361 (8) 1486 (6) 1347 (7) 1361 (7)
Feeling as if you want to be sick 1431 (7) 1290 (8) 1379 (8) 1433 (7) 1385 (9) 1243 (9) 1314 (9)
Having no appetite at all 1348 (9) 1318 (9) 1361 (9) 1292 (9) 1470 (7) 1259 (8) 1322 (8)
ranked highest ranked second highest ranked third highest ranked fourth highest
Figure 1 First and second most important concerns of European citizens by country. Legend: Sum score: sum of all first most concerning
(score = 2) and second most concerning problems (score = 1).
Figure 2 Level of concern for pain, being a burden, and
breathlessness (including 95% CI (black line) for combined first
and second most concerning) across seven European countries
(ranked by first most concerning).
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p = 0.006) but not in other countries.
The final cross-national GEE model consisted of three
factors (age, living alone and quality/quantity of life) in-
dependently associated with burden concern (Table 3).
Gender, education, paid work in last seven days, and fi-
nancial hardship were entered but not retained as they
failed to reach significance in the presence of other fac-
tors. Urbanization level and religion were not included
as there were no significant associations on a country
level. Of the six variables, only age, living alone and em-
phasis on quality of life remained significant (Table 4).
The ORs for being concerned with burdening others
increased with age and were highest in the 60–69 and
70+ groups. Once age was taken into account, people
living alone were less likely to be concerned with bur-
dening others. Also, ORs were higher for people who
preferred care to focus on quality rather than quantity of
life.
Distinctions between countries revealed that in
Germany, women were less likely to be concerned with
burden, and wishing quality rather than quantity of life
had a stronger independent influence. In Portugal, living
alone had relatively less influence on concern with bur-
dening others.
Discussion
This is the first cross-national survey assessing con-
cerns of the public when considering advanced cancer
in the last year of life. In all seven European countries
examined, being in pain, a burden to others or being
breathless ranked highest. The concern with burden
showed most variation within and between countries.
Table 3 Proportion of respondents rating “being a burden to others” as 1st or 2nd most concerning problem (crude
percentages by variables of interest)
England Flanders Germany Italy Netherlands Portugal Spain All
countries
n = 1351 n = 1269 n = 1363 n = 1352 n = 1356 n = 1286 n = 1367 n = 9344
Age ** * ** ** *
Mean age of people who are concerned
of being a burden (vs. others)
54.1 vs.
53.5
54.0 vs
51.3
48.1 vs
46.1
48.7 vs
47.3
56.4 vs
53.3
49.3 vs
48.7
48.7 vs
46.2
50.7 vs.
49.8
Age bands ** * ** * *
16–29 52.8% 20.7% 42.7% 47.2% 23.0% 39.6% 57.7% 43.9%
30–39 52.7% 16.2% 39.1% 56.3% 19.7% 42.4% 58.0% 42.8%
40–49 51.4% 22.1% 38.2% 54.5% 18.7% 37.6% 62.4% 40.2%
50–59 47.3% 28.6% 45.5% 50.2% 24.8% 42.9% 63.0% 42.6%
60–69 50.2% 27.8% 48.1% 60.6% 26.8% 41.4% 64.0% 44.1%
70+ 57.5% 31.1% 48.7% 52.5% 33.0% 44.1% 69.4% 48.1%
Gender ** *
Male 53.8% 26.2% 47.7% 53.1% 24.0% 44.4% 63.6% 44.7%
Female 50.2% 26.8% 39.2% 52.1% 25.0% 40.6% 60.7% 42.5%
Living arrangements * * **
Living alone 53.4% 26.1% 43.1% 52.7% 24.7% 31.9% 61.3% 43.9%
Living with others 45.6% 28.2% 41.3% 50.0% 24.9% 42.9% 63.4% 39.7%
Urbanisation level **
Big city or suburbs/outskirts 53.6% 25.8% 41.3% 55.5% 22.9% 43.3% 61.6% 43.6%
Town or small city 51.7% 30.0% 40.9% 50.2% 24.2% 39.8% 61.7% 45.8%
Country village 47.5% 24.9% 46.0% 54.6% 24.8% 41.1% 62.2% 40.9%
Farm or home in countryside 53.1% 29.7% 50.0% 31.3% 31.6% 38.8% 56.5% 39.4%
Marital status * **
Married or with partner 54.4% 25.9% 43.6% 54.1% 24.2% 43.2% 64.4% 43.6%
Divorced or separated 47.0% 34.7% 43.4% 52.5% 28.0% 36.8% 59.4% 43.3%
Widowed 52.5% 29.8% 50.0% 55.8% 31.3% 35.6% 66.3% 45.6%
Single 44.0% 22.9% 37.7% 46.8% 20.4% 41.4% 53.1% 40.9%
Religion **
Yes 51.3% 28.2% 42.3% 52.4% 22.9% 41.1% 60.9% 44.5%
No 51.9% 25.2% 43.3% 51.8% 26.1% 44.6% 63.3% 40.9%
Education * **
Less than primary education 52.8% 16.0% 0% 66.7% 23.8% 36.4% 60.7% 49.8%
Primary to secondary education 53.2% 23.9% 43.6% 53.7% 25.3% 41.0% 64.1% 43.9%
Post secondary to tertiary education 49.0% 29.1% 41.6% 48.8% 23.8% 44.1% 57.9% 41.2%
Activities in last seven days
Paid work * **
Yes 53.3% 25.8% 42.2% 51.4% 21.9% 42.2% 61.5% 41.8%
No 50.1% 27.5% 43.3% 53.1% 28.0% 41.3% 61.7% 44.6%
In education
Yes 50.6% 24.2% 39.8% 46.6% 33.3% 39.8% 56.6% 42.6%
No 51.7% 26.8% 43.0% 53.0% 24.2% 41.9% 62.3% 43.3%
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Table 3 Proportion of respondents rating “being a burden to others” as 1st or 2nd most concerning problem (crude
percentages by variables of interest) (Continued)
Retired
Yes 51.2% 29.5% 46.0% 55.6% 28.5% 40.7% 63.9% 44.5%
No 51.8% 25.5% 41.7% 51.3% 23.5% 42.1% 61.1% 42.8%
Financial hardship * **
Living comfortably on present income 50.8% 29.0% 42.3% 50.4% 26.2% 43.5% 60.1% 40.8%
Coping on present income 53.8% 24.5% 43.1% 55.8% 23.0% 43.3% 64.8% 45.6%
Difficult on present income 46.2% 17.2% 46.4% 48.2% 17.5% 38.4% 57.1% 43.4%
Very difficult on present income 54.3% 0% 37.5% 31.6% 25.0% 38.1% 55.7% 42.6%
Health
Very good 52.2% 28.8% 43.4% 46.1% 25.3% 44.2% 59.6% 42.6%
Good 52.5% 24.9% 41.2% 54.3% 25.0% 41.1% 63.3% 42.4%
Fair 46.2% 25.0% 47.5% 54.3% 25.4% 41.3% 62.0% 45.6%
Bad 54.3% 33.3% 39.2% 50.0% 11.9% 50.0% 58.1% 43.8%
Very bad 28.6% 33.3% 0% 66.7% 25.0% 29.4% 28.6% 28.3%
Experience of illness, death and dying
Diagnosed with seriously illness in last
5 years
Yes 52.1% 23.6% 46.6% 49.5% 27.5% 40.9% 60.5% 41.7%
No 51.5% 27.1% 42.3% 52.5% 24.3% 41.9% 61.8% 43.3%
Close relative/friend seriously ill in last
5 years
Yes 52.5% 26.9% 41.6% 52.5% 25.1% 40.9% 60.6% 43.1%
No 49.7% 25.9% 44.4% 51.4% 23.5% 43.4% 64.2% 43.3%
Death of close relative/friend in last
5 years
Yes 50.7% 27.1% 43.9% 51.0% 25.5% 43.8% 61.8% 43.4%
No 53.1% 25.2% 40.1% 55.1% 21.9% 38.6% 61.8% 42.6%
Cared for relative/friend in last months
of life
*
Yes 50.7% 29.4% 43.6% 52.0% 26.2% 39.8% 62.6% 44.1%
No 52.3% 24.0% 42.1% 52.9% 23.0% 44.2% 60.7% 42.3%
Quality or quantity of life * ** **
To extend life 37.0% 23.8% 30.0% 51.4% 22.9% 31.4% 50.0% 34.1%
Both equally important 49.6% 22.5% 38.4% 46.7% 21.3% 41.0% 60.2% 41.1%
To improve quality of life 52.8% 27.7% 44.9% 55.9% 25.8% 43.1% 62.2% 44.4%
Legend: Significant results from bivariate analysis are indicated by * (p < 0.05) and ** (p < 0.01).
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quality rather than quantity of life accounted for some
of this variation. Older age and a wish for quality in-
creased the concern with burden, whereas living alone
decreased it.
These results are based on a sound cross-national
comparison using standard methodologies and asking
identical questions across countries. Thus, the findings
provide invaluable and rare information for national and
international practice and policy indicating that moreeducation and research should focus on the top con-
cerns being a burden and being in pain.
There are also some limitations; the response rate al-
though low is similar to the declining rates of RDD sur-
veys [17]. Furthermore, there are selection biases; those
without access to a fixed telephone (29% of households
in the EU-27) [18] were excluded, and women and older
people are over-represented, due to selective non-
response. We were not able to obtain more information
from non-respondents due to the nature of the survey
Table 4 Factors associated with choosing being a burden to others as top concern in cross-national and national
models (GEE and logistic regression)
All countries (GEE) Germanya Portugala Spaina
n = 9344 n = 1208 n = 1101 n = 1226
Cross-National Variables OR OR OR OR
(95% CIs) (95% CIs) (95% CIs) (95% CIs)
Age (ref 16–29)
Age bands
30–39 1.02 (0.86–1.22) n.s. n.s. n.s.
40–49 1.01 (0.86–1.18) n.s. n.s. n.s.
50–59 1.13 (0.97–1.33) n.s. n.s. n.s.
60–69 1.26 (1.07–1.49) n.s. n.s. n.s.
70+ 1.50 (1.24–1.82) n.s. n.s. n.s.
Gender (ref male)
Female n.s. 0.69 (0.55–0.88) n.s. n.s.
Living arrangements (ref living with others)
Living alone 0.82 (0.73–0.93) n.s. 0.60 (0.39–0.93) n.s.
Quality or quantity of life (ref to extend life)
Both equally important 1.17 (0.92–1.50) 1.52 (0.79–2.93) n.s. n.s.
To improve quality of life 1.43 (1.14–1.80) 1.96 (1.05–3.66) n.s. n.s.
Country Specific Variable
Marital status (ref being married)
Divorced/separated n.s. n.s. n.s. 0.75 (0.47–1.19)
Widowed n.s. n.s. n.s. 0.91 (0.53–1.59)
Single n.s. n.s. n.s. 0.55 (0.38–0.80)
Legend: Only countries with significant variables are presented (p ≤ 0.01); a logistic regression.
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know the main reasons why people did not take part
in the study (majority due to lack of interest and lack
of time). The bias towards older people might have an
impact on our findings as older age was an independ-
ent factor predicting being concerned with burden in
all participants (although the influence of age was not
confirmed on a national level). Therefore, considering
all countries together it is possible that choosing a
burden as a top concern was overestimated in our
sample. The bias toward women might have had an
impact in Germany, as in this country women were
found to be less likely to choose burden as a top con-
cern. In this case, the concern about being a burden
might be higher for the German population than it
was in our sample.
Pain
Despite advances in pain management over the last de-
cades, nearly one in two cancer patients suffer from un-
relieved pain and the prevalence is higher in advanced
stages [19-21]. Thus, it is not surprising that the public
is most concerned about pain when imagining advancedcancer. Varied perceptions of pain might have
influenced the answers. Half of the participants had
previous experience of caring for a close relative/friend
and might have memories related to pain. Although
often understood as a primarily physical sensation,
pain could be a substitute for suffering and distress es-
pecially as a cancer diagnosis evokes images of pain,
suffering, and death [22]. Public perception seems un-
changed over the last 25 years, when cancer was con-
sidered to be an extremely painful disease relative to
other medical conditions [9].
Concerns about pain showed a clear north–south gra-
dient with respondents from Southern Europe being less
concerned than their northern counterparts. Differences
may exist between more secular Western European soci-
eties and more religious societies as in Southern Europe
with a predominantly Roman Catholic tradition where
acceptance of suffering, with physical pain may be per-
ceived as a prototype, is thought to foster spiritual
growth [23-25]. A lower opioid consumption in Southern
European countries compared to Western Europe also
reflects this [26] as well as fear that opioids may impair
cognitive function and hasten death [23].
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Self-perceived burden is thought to be a universal con-
cern across countries, important for achieving a good
death [5,10]. However, our survey showed variation with
more than half of the respondents expressing this con-
cern in Spain, Italy, and England in contrast to 25% from
the Netherlands and Flanders. Previous research shows
that self-perceived burden affects patients’ well-being;
for example, it is associated with hopelessness, quality
of life, and depression [27]. In end-of-life care situa-
tions, self-perceived burden has been found to underlie
the choice for institutionalization [28] and request for
euthanasia [29,30].
Older age was a predictor for concerns with burden.
This concurs with other results but on a cross-national
level [11,31]. The implications are important in the con-
text of ageing populations and as the cancer trajectory
increases in length, with more potential to ‘burdening
others’. The consequences are varied. For example, fear
of being a burden has been found to lead older people
to prepare for death (e.g. making a will or funeral ar-
rangements) [32]. However, it is also a key factor of the
social relationship dynamics which can erode the sense
of dignity of nursing home residents [31].
Interestingly, once the effect of age was taken into ac-
count those living alone were less concerned with being
a burden. People living alone might not have family and
others to worry about, they might be more independent
and have learnt to live by themselves and sort their
problems. Although most people wish to die at home
[33], living alone has been one of the factors identified
to preclude home death [34]. People living alone might
be aware of the higher chance to die in an institution
and thus are less worried about being a burden to their
significant others.
A considerable proportion of respondents had previ-
ous experience with serious illness such as cancer, death
and dying giving them a “double” status of being a mem-
ber of the public and affected either personally or as a
career. However, this did not influence the perception of
being a burden. Similarly, it did not influence a prefer-
ence for home death (data published elsewhere) [35].
Implications for education and clinical practice
Although palliative care has been established across
Europe and is now compulsory in many medical
schools, education about palliative care and symptom
control options does not seem to have reached the gen-
eral public sufficiently. This has already been postulated
10 years ago [10] but still seems to be topical.
A variety of factors leads to undertreatment of cancer
pain with fear of patients (e.g. to become addicted) to
utilize opioids being one of them [36]. It is therefore im-
portant for clinicians to know the expectations andconcerns of patients and family carers and to provide suf-
ficient information about pain management and opioids.
The concern of self-perceived burden has important
implications for the provision of cancer care towards the
end of life. First, it highlights the need for a holistic ap-
proach rather than a medicalization of care. Cancer care
should include a routine assessment and management of
social concerns, particularly for older patients with poor
prognosis. Second, it raises questions regarding policy
making. In many European countries, there is a trend to-
wards end-of-life care at home and in the community.
This will result in a heavier share of care on family
carers while their availability is diminishing due to chan-
ging populations, smaller families and the increasing
number of women choosing employment over caring
tasks. Therefore, self-perceived burden by patients and
its detrimental consequences will need to be addressed
by better support for family carers and better home care.Conclusions
Main public concerns for the last year of life are pain,
being a burden, and breathlessness. More public educa-
tion is needed to inform people about the potential of
palliative care but also about the non-medical aspects of
end-of-life care. Clinicians should always explore con-
cerns of patients and relatives to better understand their
perceptions and fears.
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